Barbara Handelin. Today’s biopharmaceutical companies have a primary duty baked into their corporate charter to maximize profits over all other duties, responsibilities, and objectives. While profits are necessary for a sustainable business, when they are the primary driver, every decision made is in service to them. Therefore, solving or relieving disease suffering becomes secondary to finding great market … Continue reading Applying UU Principles in the Pursuit of Public Benefit Pharmaceuticals